Skip to main content
. Author manuscript; available in PMC: 2013 Nov 19.
Published in final edited form as: Vaccine. 2012 Oct 4;30(49):10.1016/j.vaccine.2012.09.057. doi: 10.1016/j.vaccine.2012.09.057

Figure 1. Effect of prophylactic vaccination on primary vaginal HSV-2 titers.

Figure 1

Vaginal virus titers were determined by qPCR on days 1–5 after intravaginal HSV-2 challenge in guinea pigs immunized three times with Vaxfectin®-gD2 , Vaxfectin®-gD2/UL46/UL47 or saline controls. Titer values are mean ± SD genome equivalents/ml. Effect of vaccination was compared using a mixed model ANOVA on group by day. * indicates p<0.0001 compared to saline controls for both vaccinated groups.